Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Backman Johansson, Carolina
Bouva, Marelle J
de Montalembert, Marianne
Kunz, Joachim B
Marín Soria, José L
Piel, Frédéric B
MetadataShow full item record
TitleNewborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
Published inBr J Haematol 2018; 183(4):648-660
PubliekssamenvattingSickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.
- Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
- Authors: Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L
- Issue date: 2019 May
- Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
- Authors: Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D'Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J
- Issue date: 2019 Nov 13
- Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
- Authors: García-Morín M, Bardón-Cancho EJ, Beléndez C, Zamarro R, Béliz-Mendiola C, González-Rivera M, Vecilla C, Llorente-Otones L, Pérez-Alonso V, Román SS, Sebastián E, Dulín E, Cela E
- Issue date: 2020 Jul
- Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
- Authors: Tubman VN, Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MM
- Issue date: 2016 Apr
- Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
- Authors: Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE
- Issue date: 2016 Feb